Biomarin Pharmaceutical (BMRN) Q1 2019 Earnings

21FebConfirmed
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-0.25
-0.17
-0.1
-0.02

Details

Expected EPS
-0.24
Actual EPS
-0.02
Surprise EPS
0.22
Surprise Percent
+91.67%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.02 per share for Q1 2019.

0 Comments

Share your thoughts